Literature DB >> 27471635

Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate.

Sylvain Ladoire1, Laura Senovilla2, David Enot3, François Ghiringhelli4, Vichnou Poirier-Colame5, Kariman Chaba6, Gulsun Erdag7, Jochen T Schaefer7, Donna H Deacon8, Laurence Zitvogel9, Craig L Slingluff8, Guido Kroemer10.   

Abstract

Melanoma is known to be under latent immunosurveillance. Here, we studied four biomarkers of immunogenic cell stress and death (microtubule-associated proteins 1A/1B light chain 3B (MAP-LC3B, best known as LC3B)-positive puncta in the cytoplasm as a sign of autophagy; presence of nuclear HMGB1; phosphorylation of eIF2α; increase in ploidy) in melanoma cells, in tissue microarrays (TMA) from metastases from 147 melanoma patients. These biomarkers of immunogenicity were correlated with the density of immune cells infiltrating the metastases and expressing CD3, CD4(+), CD8(+), CD20, CD45, CD56, CD138, CD163, DC-LAMP or FOXP3. LC3B puncta positively correlated with the infiltration of metastases by CD163(+) macrophages, while expression of HMGB1 correlated with infiltration by FOXP3(+) regulatory T cells and CD56(+) lymphocytes. eIF2α phosphorylation was associated with an augmentation of nuclear diameters, reflecting an increase in ploidy. Interestingly, therapeutic vaccination led to a reduction of eIF2α phosphorylation suggestive of immunoselection against cells bearing this sign of endoplasmic reticulum (ER) stress. None of the stress/death-related biomarkers had a significant prognostic impact, contrasting with the major prognostic effect of the ratio of cytotoxic T lymphocytes (CTL) over immunosuppressive FOXP3(+) and CD163(+) cells. Altogether, these results support the idea of a mutual dialog between, on one hand, melanoma cells with their cell-intrinsic stress pathways and, on the other hand, immune effectors. Future work is required to understand the detailed mechanisms of this interaction.

Entities:  

Keywords:  Autophagy; HMGB1; LC3; immune infiltrates; immunogenic cell death; melanoma

Year:  2016        PMID: 27471635      PMCID: PMC4938307          DOI: 10.1080/2162402X.2016.1160193

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  39 in total

1.  Checkpoints.

Authors:  James P Allison
Journal:  Cell       Date:  2015-09-10       Impact factor: 41.582

2.  Calreticulin exposure dictates the immunogenicity of cancer cell death.

Authors:  Michel Obeid; Antoine Tesniere; François Ghiringhelli; Gian Maria Fimia; Lionel Apetoh; Jean-Luc Perfettini; Maria Castedo; Grégoire Mignot; Theoharis Panaretakis; Noelia Casares; Didier Métivier; Nathanael Larochette; Peter van Endert; Fabiola Ciccosanti; Mauro Piacentini; Laurence Zitvogel; Guido Kroemer
Journal:  Nat Med       Date:  2006-12-24       Impact factor: 53.440

3.  An immunosurveillance mechanism controls cancer cell ploidy.

Authors:  Laura Senovilla; Ilio Vitale; Isabelle Martins; Maximilien Tailler; Claire Pailleret; Mickaël Michaud; Lorenzo Galluzzi; Sandy Adjemian; Oliver Kepp; Mireia Niso-Santano; Shensi Shen; Guillermo Mariño; Alfredo Criollo; Alice Boilève; Bastien Job; Sylvain Ladoire; François Ghiringhelli; Antonella Sistigu; Takahiro Yamazaki; Santiago Rello-Varona; Clara Locher; Vichnou Poirier-Colame; Monique Talbot; Alexander Valent; Francesco Berardinelli; Antonio Antoccia; Fabiola Ciccosanti; Gian Maria Fimia; Mauro Piacentini; Antonio Fueyo; Nicole L Messina; Ming Li; Christopher J Chan; Verena Sigl; Guillaume Pourcher; Christoph Ruckenstuhl; Didac Carmona-Gutierrez; Vladimir Lazar; Josef M Penninger; Frank Madeo; Carlos López-Otín; Mark J Smyth; Laurence Zitvogel; Maria Castedo; Guido Kroemer
Journal:  Science       Date:  2012-09-28       Impact factor: 47.728

4.  The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer.

Authors:  Sylvain Ladoire; David Enot; Laura Senovilla; François Ghiringhelli; Vichnou Poirier-Colame; Kariman Chaba; Michaela Semeraro; Marie Chaix; Frédérique Penault-Llorca; Laurent Arnould; Marie Laure Poillot; Patrick Arveux; Suzette Delaloge; Fabrice Andre; Laurence Zitvogel; Guido Kroemer
Journal:  Autophagy       Date:  2016-03-16       Impact factor: 16.016

Review 5.  Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance.

Authors:  Laurence Zitvogel; Lorenzo Galluzzi; Mark J Smyth; Guido Kroemer
Journal:  Immunity       Date:  2013-07-25       Impact factor: 31.745

6.  Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Authors:  Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Michel Obeid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; M Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastian Amigorena; Bernard Ryffel; Franck J Barrat; Paul Saftig; Francis Levi; Rosette Lidereau; Catherine Nogues; Jean-Paul Mira; Agnès Chompret; Virginie Joulin; Françoise Clavel-Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2007-08-19       Impact factor: 53.440

7.  Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells.

Authors:  Yuting Ma; Sandy Adjemian; Stephen R Mattarollo; Takahiro Yamazaki; Laetitia Aymeric; Heng Yang; João Paulo Portela Catani; Dalil Hannani; Helene Duret; Kim Steegh; Isabelle Martins; Frederic Schlemmer; Mickaël Michaud; Oliver Kepp; Abdul Qader Sukkurwala; Laurie Menger; Erika Vacchelli; Nathalie Droin; Lorenzo Galluzzi; Roman Krzysiek; Siamon Gordon; Philip R Taylor; Peter Van Endert; Eric Solary; Mark J Smyth; Laurence Zitvogel; Guido Kroemer
Journal:  Immunity       Date:  2013-04-04       Impact factor: 31.745

Review 8.  Natural and therapy-induced immunosurveillance in breast cancer.

Authors:  Guido Kroemer; Laura Senovilla; Lorenzo Galluzzi; Fabrice André; Laurence Zitvogel
Journal:  Nat Med       Date:  2015-10       Impact factor: 53.440

9.  Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies.

Authors:  Gautier Stoll; Gabriela Bindea; Bernhard Mlecnik; Jérôme Galon; Laurence Zitvogel; Guido Kroemer
Journal:  Oncotarget       Date:  2015-05-20

10.  Morphometric analysis of immunoselection against hyperploid cancer cells.

Authors:  Norma Bloy; Allan Sauvat; Kariman Chaba; Aitziber Buqué; Juliette Humeau; José Manuel Bravo-San Pedro; Jack Bui; Oliver Kepp; Guido Kroemer; Laura Senovilla
Journal:  Oncotarget       Date:  2015-12-01
View more
  6 in total

1.  Tumor SQSTM1 (p62) expression and T cells in colorectal cancer.

Authors:  Keisuke Kosumi; Yohei Masugi; Juhong Yang; Zhi Rong Qian; Sun A Kim; Wanwan Li; Yan Shi; Annacarolina da Silva; Tsuyoshi Hamada; Li Liu; Mancang Gu; Tyler S Twombly; Yin Cao; David A Barbie; Katsuhiko Nosho; Hideo Baba; Wendy S Garrett; Jeffery A Meyerhardt; Edward L Giovannucci; Andrew T Chan; Charles S Fuchs; Shuji Ogino; Reiko Nishihara
Journal:  Oncoimmunology       Date:  2017-01-31       Impact factor: 8.110

2.  The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.

Authors:  Satu Salmi; Anton Lin; Benjamin Hirschovits-Gerz; Mari Valkonen; Niina Aaltonen; Reijo Sironen; Hanna Siiskonen; Sanna Pasonen-Seppänen
Journal:  BMC Cancer       Date:  2021-05-29       Impact factor: 4.430

3.  Oncolytic virotherapy enhances the efficacy of a cancer vaccine by modulating the tumor microenvironment.

Authors:  Iris Koske; Annika Rössler; Lisa Pipperger; Monika Petersson; Isabel Barnstorf; Janine Kimpel; Christoph H Tripp; Patrizia Stoitzner; Zoltán Bánki; Dorothee von Laer
Journal:  Int J Cancer       Date:  2019-04-29       Impact factor: 7.396

4.  Non-thermal plasma modulates cellular markers associated with immunogenicity in a model of latent HIV-1 infection.

Authors:  Hager Mohamed; Ramona Clemen; Eric Freund; Jan-Wilm Lackmann; Kristian Wende; Jennifer Connors; Elias K Haddad; Will Dampier; Brian Wigdahl; Vandana Miller; Sander Bekeschus; Fred C Krebs
Journal:  PLoS One       Date:  2021-03-01       Impact factor: 3.240

5.  Toxicity and Immunogenicity in Murine Melanoma following Exposure to Physical Plasma-Derived Oxidants.

Authors:  Sander Bekeschus; Katrin Rödder; Bob Fregin; Oliver Otto; Maxi Lippert; Klaus-Dieter Weltmann; Kristian Wende; Anke Schmidt; Rajesh Kumar Gandhirajan
Journal:  Oxid Med Cell Longev       Date:  2017-06-27       Impact factor: 6.543

6.  LC3B in Malignant Cells Correlates With Immune Infiltrate in Hypopharyngeal Squamous Cell Carcinoma.

Authors:  Sifan Gao; Jun Chen; Xiaowen Han; Dangjun Wei; Zhengsheng Wu; Chaobing Gao
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.